Your Location:
Home >
Browse articles >
Effect of Modified Erchentang on Expressions of Chemokine Receptor CXCR1/2 and CXCL8 in Patients with AECOPD
Classic Prescriptions | Updated:2021-02-09
Effect of Modified Erchentang on Expressions of Chemokine Receptor CXCR1/2 and CXCL8 in Patients with AECOPD
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 25, Issue 24, Pages: 1-8(2019)
DOI: 10.13422/j.cnki.syfjx.20192406
Scan QR Code
Full Text(HTML)
Figs( 2 ) Tabs( 5 )
References
Publication Info
Metrics
105
Views
111
Downloads
5
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Mechanism of Modified Erchentang on COPD Inflammation Based on TNF-α/TNFR1/RIPKs Pathway
Modified Erchentang Alleviates Inflammation in Chronic Obstructive Pulmonary Disease via Midkine/Notch2/Hey1 Signaling Pathway in Rats
Effect of Modified Erchentang on CC16, SP-D and HAT and HDAC in Patients at Acute Exacerbation Stage of COPD
Effect of Modified Erchentang on Hif-1 and Sirtuins 1 in Patients with COPD
Exploring Multi-target Synergistic Mechanisms of Compound Yiqi Weixue Prescription with Medicinal and Edible Value in Alleviating Premenstrual Syndrome Based on Transcriptomics
Related Author
CHEN Zhuang
LIU Gaoyang
XIE Wenying
SHANG Lizhi
HU Wenhao
LI Yaoyang
LIU Gaoyang
CHEN Zhuang
Related Institution
Henan Provincial Second People's Hospital
School of Pharmacy, Anhui University of Chinese Medicine
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine(TCM),Tianjin/National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion
Graduate School of Tianjin University of TCM


